Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=11
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=11
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=11
PubPharm (3.278)
101
A study on the immune response and safety of an adjuvanted human papillomavirus vaccine when given to healthy women 16 to 26 years of age : A Phase 1/2 randomized, observer-blinded, multi-country study to evaluate safety and immunogenicity of investigational adjuvanted human papillomavirus vaccine in females (16 to 26 years of age) - HPV9-AS04-001
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
102
Phase 1/2 Substudy of Investigation Agents in PD-1/L1 Refractory Locally Advanced (Inoperable) or Metastatic Urothelial (Bladder) Cancer : A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Study of Investigational Agents With or Without Pembrolizumab in Participants with PD-1/L1 Refractory Locally Advanced or Metastatic Urothelial Carcinoma (KEYMAKER-U04): Substudy 04A - Phase 1/2 Substudy of Investigational Agents in PD-1/L1 Refractory Locally Advanced or mUC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
103
Safety and Efficacy of OC-1 Cell Therapy in Patients With Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma : Safety and efficacy of hCD1a-CAR T (OC-1) therapy, in patients with relapsed/refractory (R/R) T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LL) - CARxALL
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
104
LAVA-1207 Open Label study in patients with therapy refractory metastatic castration resistant prostate cancer : A Phase 1 and 2a open-label trial to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity of LAVA-1207, a PSMA-targeting bispecific ?d-T cell engager, in patients with therapy refractory metastatic castration resistant prostate cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
105
Safety, immunogenicity and efficacy of GSK S. aureus candidate vaccine (GSK3878858A) when administered to healthy adults (dose-escalation) and to adults 18 to 64 years of age with a recent S. aureus skin and soft tissue infection (SSTI). : A Phase I/II, observer-blind, randomised, placebo-controlled study to assess safety, immunogenicity and efficacy of GSK S. aureus candidate vaccine when administered to healthy adults (dose-escalation) and to adults 18 to 64 years of age with a recent S. aureus skin and soft tissue infection (SSTI). - STAPH AUREUS BIOCONJ-001 STG
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
106
A study on the immune response and safety of an adjuvanted human papillomavirus vaccine when given to healthy women 16 to 26 years of age : A Phase 1/2 randomized, observer-blinded, multi-country study to evaluate safety and immunogenicity of investigational adjuvanted human papillomavirus vaccine in females (16 to 26 years of age) - HPV9-AS04-001
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
107
A study of GB5121 in adults with cancer of the central nervous system that has reappeared or did not respond to prior therapy : A Phase 1b/2, open-label dose escalation with expansion study of GB5121 in adult patients with relapsed/refractory primary or secondary central nervous system lymphoma or primary vitreoretinal lymphoma, with a Phase 2 open-label single dose level study of GB5121 in adult patients with relapsed/refractory primary central nervous system lymphoma - STAR CNS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
108
A study of ANV419 alone or in combination with approved treatment in patients with cutaneous melanoma : A Phase 1/2 Study of ANV419 as Monotherapy or in Combination With Anti PD-1 or Anti-CTLA-4 Antibody Following Anti PD 1/Anti-PD-L1 Antibody Treatment in Patients With Unresectable or Metastatic Cutaneous Melanoma - OMNIA-1
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
109
A Study Evaluating Bemarituzumab in Solid Tumors with Fibroblast growth factor receptor 2b (FGFR2b) Overexpression : A Phase 1b/2, Multicenter, Open-label Basket Study Evaluating the Safety and Efficacy of Bemarituzumab Monotherapy in Solid Tumors with FGFR2b Overexpression (FORTITUDE 301)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
110
A study on the immune response and safety of an adjuvanted human papillomavirus vaccine when given to healthy women 16 to 26 years of age : A Phase 1/2 randomized, observer-blinded, multi-country study to evaluate safety and immunogenicity of investigational adjuvanted human papillomavirus vaccine in females (16 to 26 years of age) - HPV9-AS04-001
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
[1]
« Vorheriger
6
7
8
9
10
11
12
13
14
15
16
Nächster »
[328]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 1
Medienart
3.278
Aufsätze
3.278
E-Artikel
3.278
E-Ressourcen
Zeitschriftentitel
3.278
WHO International Clinical Trials Registry Plat...
Thema
3.278
610
Phase: Phase 1
3.278
Recruitment Status: Authorised-recruitment may ...
3.278
Study Type: Interventional
26
Medical Condition: Advanced Solid Tumors MedDRA...
18
Medical Condition: B-cell Non-Hodgkin LymphomaD...
18
Medical Condition: High grade serous ovarian ca...
18
Medical Condition: Metastatic Castration-Resist...
18
Medical Condition: Relapsed or Refractory Multi...
14
Medical Condition: Huntington's Disease MedDRA ...
14
Medical Condition: KRAS p.G12C mutant advanced ...
14
Medical Condition: Melanoma MedDRA version: 21....
14
Medical Condition: Relapsed or Refractory Acute...
14
Medical Condition: The ‘wet’ form of age-re...
14
Medical Condition: pediatric CD22-positive rela...
12
Medical Condition: PMF or PPV- MF, or PET- MF M...
12
Medical Condition: Pediatric patients with Phil...
12
Medical Condition: Primary Myelofibrosis (PMF),...
12
Medical Condition: Relapsed/Refractory Myelofib...
12
Medical Condition: Solid Tumors MedDRA version:...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2.510
2020-
768
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
3.240
Englisch
34
Unbestimmt
4
Italienisch
Haven't found what you're looking for?
Wird geladen...